Global prevalence of systemic and localized autoimmune disorders, emergence of various government initiatives and enhanced ability to spend on the treatment of these ailments will stimulate autoimmune disease diagnostics market trends.
Global prevalence of systemic and localized autoimmune disorders, emergence of various government initiatives and enhanced ability to spend on the treatment of these ailments will stimulate autoimmune disease diagnostics market trends. The American Autoimmune Related Diseases Association (AARDA) revealed that over 50 million residents in the U.S. are diagnosed with autoimmune disorders, and this patient pool is likely to surge in the coming years.
This factor is urging the growth of multiple strategies to tend to the treatment and the costs of these diseases. Also, the occurrence of autoimmune diseases is found to be 75% more in women as compared to men and is one of the top ten mortality factors for women in all age groups.
Reportedly, the global autoimmune disease diagnostics market size is projected to reach a yearly valuation of more than USD 16 billion by 2025.
Increased demand across the U.S. and Asia Pacific
U.S. recorded the highest demand for autoimmune disease diagnosis in the North American regional industry and contributed to a revenue close to USD 5 billion in 2018. The growth can be attributed towards the existence of sophisticated healthcare services and amenities in the country. There is also an incrementing awareness related to the advantages of early and accurate diagnosis of the diseases along with a higher healthcare spending capability of the regional population.
Asia Pacific market will foresee a substantial revenue share over the coming years due to the expanding patient population. There is a better awareness of autoimmune diseases and emerging advancements in the healthcare sector across the developing Asian countries.
To access sample pages of this report titled, “Autoimmune Disease Diagnostics Market Size by Product (Systemic {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus}, Localized), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents, please click on the link below:
https://www.gminsights.com/request-sample/detail/618
Consistent use for localized and systemic diseases
Market value from localized autoimmune disease diagnostic tests reached 66% of the total revenue share in 2018. This can be owed to the increased adoption of diagnostics kits and assays with the recurring incidences of autoimmune disorders like Hashimoto’s thyroiditis, type 1 diabetes, and pernicious anemia in consumers. An increase in awareness across patients resulting from favorable government efforts will further boost product consumption.
Annual revenue for the autoimmune disease diagnostics market from systemic disorders will witness a 3.9% CAGR through 2025, with technical developments in multiple autoantibodies screening tests to assist in the early diagnosis and treatment of the diseases. For instance, in October 2020, Amgen, a U.S. based pharma company, rolled-out a safety trial for the diagnostics to treat Systemic Lupus Erythematosus (SLE).
Growth from competitive marketing strategies
Service providers of autoimmune disease testing are keen on implanting various strategic decisions to enhance and expand their business portfolio to offer effective results in diagnostics, besides sustaining market competition. The currently active coronavirus pandemic has also significantly influenced the adoption of diagnostic tests and trials to a considerable extent.
Abbott Laboratories, BioMerieux SA, AESKU Diagnostics, Euroimmun, Inova diagnostics Inc, Bio-Rad Laboratories, Inc Siemens AG, Beckman Coulter Inc., SQI Diagnostics, and Quest Diagnostics are some of the prominent companies offering autoimmune disease diagnostic products worldwide.
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com